Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for treating acute gastroenteritis in children. An update
Open accessAbstract
The effectiveness of Lactobacillus reuteri DSM 17938 (L. reuteri) for the management of acute gastroenteritis (AGE) has been recently questioned. We performed a systematic review to update evidence on L. reuteri for treating AGE in children. We searched MEDLINE, EMBASE, the Cochrane Library databases, and additional data sources from January 2016 (end of search for our 2016 systematic review) to August 2019. The primary outcomes were stool volume and duration of diarrhea. Four RCTs were included. None of them evaluated stool volume. Compared with placebo or no treatment, L. reuteri reduced diarrhea duration (four RCTs, n = 347, mean difference, MD −0.87 days, 95% CI [−1.43, −0.31]). L. reuteri use was also associated with a reduced duration of hospitalization (three RCTs, n = 284, MD −0.54 days, 95% CI [−1.09, 0.0]). The small effect sizes of limited clinical relevance and methodological limitations of the included trials should be noted when interpreting these findings.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A systematic review of L reuteri DSM 17938 for treating acute gastroenteritis in children reported marked statistical heterogeneity and very low certainty of evidence for both duration of diarrhoea and duration of hospitalization.
“A systematic review of L reuteri DSM 17938 for treating acute gastroenteritis in children reported marked statistical heterogeneity and very low certainty of evidence for both duration of diarrhoea and duration of hospitalization (Patro‐Gołab 2019).”
From Probiotics for treating acute infectious diarrhoea (2020) · cites this paper as Patro‐Gołab 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1× · see citing works
“The GRADE system offers four categories of the quality of the evidence (high; moderate; low; and very low) [16].”
BackgroundGuarino, A., Ashkenazi, S., Gendrel, D., Lo Vecchio, A., Shamir, R., & Szajewska, H. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000375 · Cited by 935 · see citing works
Self-citationChoosing an appropriate probiotic product for your patient: An evidence-based practical guide
Sniffen, J. C., McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209205 · Cited by 265 · see citing works
Florez, I. D., Veroniki, A.-A., Al Khalifah, R., Yepes-Nuñez, J. J., Sierra, J. M., Vernooij, R. W. M., Acosta-Reyes, J., Granados, C. M., Pérez-Gaxiola, G., Cuello-Garcia, C., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0207701 · Cited by 87 · see citing works
Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children
Applegate, J. A., Fischer Walker, C. L., Ambikapathi, R., & Black, R. E. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-s3-s16 · Cited by 87 · see citing works
Flagged first, then by citations
Research works printed but not linked: 34
- [1]GBD Diarrhoeal Disease Collaborators Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: A systematic analysis for the Global Burden of Disease Study 2016 Lancet Infect. Dis. 2018 18 1211 1228 10.1016/S1473-3099(18)30362-1 30243583 PMC6202444 · DOI
- [2]Barker S.F. Zomer E. O’Toole J. Sinclair M. Gibney K. Liew D. Leder K. Cost of gastroenteritis in Australia: A healthcare perspective PLoS ONE 2018 13 e0195759 10.1371/journal.pone.0195759 29649285 PMC5896984 · DOI
- [4]Rosander A. Connolly E. Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938 Appl. Environ. Microbiol. 2008 74 6032 6040 10.1128/AEM.00991-08 18689509 PMC2565949 · DOI
- [5]Mu Q. Tavella V.J. Luo X.M. Role of Lactobacillus reuteri in Human Health and Diseases Front. Microbiol. 2018 9 757 10.3389/fmicb.2018.00757 29725324 PMC5917019 · DOI · Paper page
- [6]Urbanska M. Gieruszczak-Bialek D. Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children Aliment. Pharmacol. Ther. 2016 43 1025 1034 10.1111/apt.13590 26991503 · DOI
- [7]Dinleyici E.C. Vandenplas Y. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children Acta Paediatr. 2014 103 e300 e305 10.1111/apa.12617 24579935 · DOI
- [8]Dinleyici E.C. Dalgic N. Guven S. Metin O. Yasa O. Kurugol Z. Turel O. Tanir G. Yazar A.S. Arica V. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting Jornal Pediatria (Versão Português) 2015 91 392 396 10.1016/j.jpedp.2015.05.008 25986615 · DOI
- [9]Francavilla R. Lionetti E. Castellaneta S. Ciruzzi F. Indrio F. Masciale A. Fontana C. La Rosa M.M. Cavallo L. Francavilla A. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhea—A double-blind study Aliment. Pharmacol. Ther. 2012 36 363 369 10.1111/j.1365-2036.2012.05180.x 22680836 · DOI
- [10]Schnadower D. Tarr P.I. Casper T.C. Gorelick M.H. Dean J.M. O’Connell K.J. Mahajan P. Levine A.C. Bhatt S.R. Roskind C.G. Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children N. Engl. J. Med. 2018 379 2002 2014 10.1056/NEJMoa1802598 30462938 PMC6358014 · DOI · Paper page
- [11]Freedman S.B. Williamson-Urquhart S. Farion K.J. Gouin S. Willan A.R. Poonai N. Hurley K. Sherman P.M. Finkelstein Y. Lee B.E. Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis N. Engl. J. Med. 2018 379 2015 2026 10.1056/NEJMoa1802597 30462939 · DOI
- [12]Szymanski H. Szajewska H. Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis: A Randomized Controlled Trial Pediatr. Infect. Dis. J. 2019 38 e237 e242 10.1097/INF.0000000000002355 31033909 · DOI
- [13]Szajewska H. Guarino A. Hojsak I. Indrio F. Kolacek S. Shamir R. Vandenplas Y. Weizman Z. Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN Working Group for Probiotics and Prebiotics J. Pediatr. Gastroenterol. Nutr. 2014 58 531 539 10.1097/MPG.0000000000000320 24614141 · DOI
- [14]Liberati A. Altman D.G. Tetzlaff J. Mulrow C. Gotzsche P.C. Ioannidis J.P. Clarke M. Devereaux P.J. Kleijnen J. Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration BMJ 2009 339 b2700 10.1136/bmj.b2700 19622552 PMC2714672 · DOI · Paper page
- [15]Egger M. Davey Smith G. Schneider M. Minder C. Bias in meta-analysis detected by a simple, graphical test BMJ 1997 315 629 634 10.1136/bmj.315.7109.629 9310563 PMC2127453 · DOI · Paper page
- [17]Ruzhentsova T.A. Ploskireva A.A. Popova R.V. Nuribekov S.A. Gorelov A.V. Optimization of Pathogenetic Therapy of Acute Intestinal Infections in Children: Results of a Randomised Trial Infect. Dis. 2018 1670 1676 10.20953/1729-9225-2018-2-70-76 · DOI
- [18]Szajewska H. Urbanska M. Chmielewska A. Weizman Z. Shamir R. Meta-analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children Benef. Microbes 2014 5 285 293 10.3920/BM2013.0056 24463209 · DOI
- [19]Ahmadi E. Alizadeh-Navaei R. Rezai M.S. Efficacy of probiotic use in acute rotavirus diarrhea in children: A systematic review and meta-analysis Casp. J. Intern. Med. 2015 6 187 195 PMC4649266 26644891
- [20]Allen S.J. Martinez E.G. Gregorio G.V. Dans L.F. Probiotics for treating acute infectious diarrhoea Cochrane Database Syst. Rev. 2010 10.1002/14651858.CD003048.pub3 PMC6532699 21069673 · DOI · Paper page
- [23]Freedman S.B. Pasichnyk D. Black K.J. Fitzpatrick E. Gouin S. Milne A. Hartling L. Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis PLoS ONE 2015 10 e0128754 10.1371/journal.pone.0128754 26075617 PMC4468143 · DOI
- [24]Gutierrez-Castrellon P. Ortiz-Hernandez A.A. Llamosas-Gallardo B. Acosta-Bastidas M.A. Jimenez-Gutierrez C. Diaz-Garcia L. Anzo-Osorio A. Estevez-Jimenez J. Jimenez-Escobar I. Vidal-Vazquez R.P. Efficacy of racecadotril vs. smectite, probiotics or zinc as an integral part of treatment of acute diarrhea in children under five years: A meta-analysis of multiple treatments Gac. Med. Mex. 2015 151 329 337 26089269
- [25]Salari P. Nikfar S. Abdollahi M. A meta-analysis and systematic review on the effect of probiotics in acute diarrhea Inflamm. Allergy Drug Targets 2012 11 3 14 10.2174/187152812798889394 22309079 · DOI
- [27]Szajewska H. Kolodziej M. Gieruszczak-Bialek D. Skorka A. Ruszczynski M. Shamir R. Systematic review with meta-analysis: Lactobacillus rhamnosus GG for treating acute gastroenteritis in children—A 2019 update Aliment. Pharmacol. Ther. 2019 49 1376 1384 10.1111/apt.15267 31025399 · DOI
- [28]Schnadower D. Tarr P.I. Freedman S.B. Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis Aliment. Pharmacol. Ther. 2019 50 620 622 10.1111/apt.15418 31414542 · DOI
- [29]Dinleyici E.C. Kara A. Ozen M. Vandenplas Y. Saccharomyces boulardii CNCM I-745 in different clinical conditions Expert Opin. Biol. Ther. 2014 14 1593 1609 10.1517/14712598.2014.937419 24995675 · DOI
- [30]Feizizadeh S. Salehi-Abargouei A. Akbari V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea Pediatrics 2014 134 e176 e191 10.1542/peds.2013-3950 24958586 · DOI
- [31]Padayachee M. Visser J. Viljoen E. Musekiwa A. Blaauw R. Efficacy and safety of Saccharomyces boulardii in the treatment of acute gastroenteritis in the paediatric population: A systematic review S. Afr. J. Clin. Nutr. 2019 32 58 69 10.1080/16070658.2018.1449378 · DOI · Paper page
- [32]Ianiro G. Rizzatti G. Plomer M. Lopetuso L. Scaldaferri F. Franceschi F. Cammarota G. Gasbarrini A. Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Nutrients 2018 10 1074 10.3390/nu10081074 30103531 PMC6116021 · DOI
- [34]Hegar B. Waspada I.M. Gunardi H. Vandenplas Y. A double blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children Indian J. Pediatr. 2015 82 410 414 10.1007/s12098-014-1408-5 24777621 · DOI
- [35]Freedman S.B. Sherman P.M. Willan A. Johnson D. Gouin S. Schuh S. Pediatric Emergency Research Canada Emergency Department Treatment of Children with Diarrhea Who Attend Day Care: A Randomized Multidose Trial of a Lactobacillus helveticus and Lactobacillus rhamnosus Combination Probiotic Clin. Pediatr. 2015 54 1158 1166 10.1177/0009922815569200 25669920 · DOI · Paper page
- [36]Rosenfeldt V. Michaelsen K.F. Jakobsen M. Larsen C.N. Moller P.L. Pedersen P. Tvede M. Weyrehter H. Valerius N.H. Paerregaard A. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea Pediatr. Infect. Dis. J. 2002 21 411 416 10.1097/00006454-200205000-00012 12150178 · DOI
- [37]Rosenfeldt V. Michaelsen K.F. Jakobsen M. Larsen C.N. Moller P.L. Tvede M. Weyrehter H. Valerius N.H. Paerregaard A. Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers Pediatr. Infect. Dis. J. 2002 21 417 419 10.1097/00006454-200205000-00013 12150179 · DOI
- [38]Huang Y.F. Liu P.Y. Chen Y.Y. Nong B.R. Huang I.F. Hsieh K.S. Chen K.T. Three-combination probiotics therapy in children with salmonella and rotavirus gastroenteritis J. Clin. Gastroenterol. 2014 48 37 42 10.1097/MCG.0b013e31828f1c6e 23632352 · DOI
- [39]Chen C.C. Kong M.S. Lai M.W. Chao H.C. Chang K.W. Chen S.Y. Huang Y.C. Chiu C.H. Li W.C. Lin P.Y. Probiotics have clinical, microbiologic, and immunologic efficacy in acute infectious diarrhea Pediatr. Infect. Dis J. 2010 29 135 138 10.1097/INF.0b013e3181b530bf 20135748 · DOI
- [40]Athalye-Jape G. Rao S. Patole S. Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review JPEN J. Parenter. Enter. Nutr. 2016 40 783 794 10.1177/0148607115588113 26059900 · DOI
Cited by
Sorted by citations
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
Guarner, F., Sanders, M. E., Szajewska, H., Cohen, H., Eliakim, R., Herrera-deGuise, C., Karakan, T., Merenstein, D., Piscoya, A., Ramakrishna, B., et al. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002002 · Cited by 209 · see citing works
Self-citationProbiotics for treating acute infectious diarrhoea
Collinson, S., Deans, A., Padua-Zamora, A., Gregorio, G. V., Li, C., Dans, L. F., & Allen, S. J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003048.pub4 · Cited by 153 · see citing works
Use of Probiotics for the Management of Acute Gastroenteritis in Children: An Update
Szajewska, H., Guarino, A., Hojsak, I., Indrio, F., Kolacek, S., Orel, R., Salvatore, S., Shamir, R., van Goudoever, J. B., Vandenplas, Y., et al. (2020) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002751 · Cited by 90 · see citing works
Self-citation
- Authors
- Patro-Gołąb, B., & Szajewska, H.
- Affiliations
- Medical University of Warsaw (PL)
- Corresponding author
- Szajewska, Hania
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-11-14
- Volume
- 11
- Issue
- 11
- Pages
- 2762
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6893691
- OpenAlex
- W2986401148
- Cited by
- 49
- References
- 5
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 8 · 2020: 5
- FWCI
- 0.47
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Keywords
- Lactobacillus reuteri DSM 17938, acute gastroenteritis, childhood diarrhea, probiotics, diarrhea duration, length of hospital stay, stool volume
- MeSH terms
- Child, Preschool, Defecation, Diarrhea, Feces, Gastroenteritis, Hospitalization, Humans, Infant, Species Specificity, Probiotics, Limosilactobacillus reuteri
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review